Connect Education Workshops About Diffuse Large B-Cell Lymphoma

Past Workshops

1. Diffuse Large B-Cell Lymphoma (DLBCL): Treatment Updates
   Tags:

   diffuse large b-cell lymphomalymphomatreatment
2. Updates on CAR T-cell Therapies
   Tags:

   acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyelofibrosismyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomapolycythemia verasmall lymphocytic lymphomawaldenstrom’s macroglobulinemiacar t-cell therapyimmunotherapytreatment
3. Update from the 2024 American Society of Hematology (ASH) Annual Meeting
   Tags:

   acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyelofibrosismyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomapolycythemia verasmall lymphocytic lymphomawaldenstrom’s macroglobulinemiatreatmentclinical trialsdoctor-patient communication
4. Update on CAR T-Cell Therapies
   Tags:

   acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyelofibrosismyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomapolycythemia verasmall lymphocytic lymphomawaldenstrom’s macroglobulinemiacar t-cell therapyimmunotherapytreatmentdoctor-patient communicationside effects
5. Diffuse Large B-Cell Lymphoma (DLBCL): New Treatment Approaches for Relapsed Refractory DLBCL
   Tags:

   diffuse large b-cell lymphomalymphomatreatment
6. Taking Your Blood Cancer Adherence Treatment on Schedule
   Tags:

   acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyelofibrosismyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomapolycythemia verasmall lymphocytic lymphomawaldenstrom’s macroglobulinemiaadherencetreatment
7. CAR T-Cell Therapy: What’s New
   Tags:

   acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomanon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomacar t-cell therapyimmunotherapytargeted treatmentstreatment
8. Diffuse Large B-Cell Lymphoma (DLBCL): Treatment Updates
   Tags:

   diffuse large b-cell lymphomalymphomatreatment
9. Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
   Tags:

   breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapyside effectstargeted treatmentstreatmentpersonalized medicine
10. Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
    Tags:

    breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomamelanomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapypersonalized medicineside effectstreatmenttargeted treatments